Form 4: Delcath Systems Chief Medical Officer Acquires Stock Options

Vojo Vukovic, Chief Medical Officer of Delcath Systems, Inc., reports the acquisition of stock options exercisable for 113,000 shares of common stock.

Summary

• Vojo Vukovic, the Chief Medical Officer of Delcath Systems, Inc., filed a Form 4 on February 7, 2025.
• The filing reports the acquisition of stock options representing the right to buy 113,000 shares of Delcath Systems common stock.
• The exercise price of the stock options is $16.25.
• The options vest monthly over three years, starting February 7, 2025, contingent upon continued employment with Delcath Systems, Inc.
• The options expire on February 7, 2035.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing regarding stock option grants, and does not inherently convey positive or negative sentiment. It's a neutral disclosure.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

This filing is a routine disclosure related to executive compensation and is common in publicly traded companies. It reflects the company's ongoing efforts to incentivize and retain key personnel.

Stakeholder Impact

• The granting of stock options aligns management's interests with those of shareholders, potentially incentivizing value creation.

Key Dates

Keywords

Delcath Systems, Stock Options, Form 4, Vukovic, Chief Medical Officer, DCTH, Beneficial Ownership, Equity Incentive Plan